icone plus
Contact
Abonnez-vous aux actualités
Reason for request
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
hpeUD2Qbbt0R3eK7